Site 0143 - HonorHealth

The trials here

What the trial at this site is about, from its registry record.

Conditions

• Ovarian cancer

Running trials

• Recruiting

  A Study of Azenosertib (ZN-c3) in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer

  NCT05128825· Phase 2· K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc· Source

  Contact: Project Director

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Ovarian cancer1 recruiting